Preparation, Characterization, and Anti-Lung Cancer Activity of Tetrandrine-Loaded Stealth Liposomes
Zhengyu Fang,Peihong Lin,Rui Gao,Wenjing Yang,Aizhen Zhou,Wenying Yu
DOI: https://doi.org/10.2147/ijn.s431599
IF: 7.033
2024-01-25
International Journal of Nanomedicine
Abstract:Zhengyu Fang, 1, &ast Peihong Lin, 1, &ast Rui Gao, 1, &ast Wenjing Yang, 1 Aizhen Zhou, 2 Wenying Yu 1, 3 1 School of Pharmacy, Hangzhou Medical College, Hangzhou, 310013, People's Republic of China; 2 Department of Traditional Chinese Medicine, Zhejiang Pharmaceutical University, Ningbo, 315500, People's Republic of China; 3 Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, 310013, People's Republic of China &astThese authors contributed equally to this work Correspondence: Aizhen Zhou; Wenying Yu, Tel +86 571 88215623, Email ; Background: Tetrandrine (Tet), a bisbenzylisoquinoline alkaloid, is a potential candidate for cancer chemotherapy. However, Tet has poor aqueous solubility and a short half-life, which limits its bioavailability and efficacy. Liposomes have been widely utilized to enhance the bioavailability and efficacy of drugs. Methods: In this study, Tet-loaded stealth liposomes (S-LPs@Tet) were prepared by ethanol injection method. Furthermore, physicochemical characterisation, biopharmaceutical behaviour, therapeutic efficacy, and biocompatibility of S-LPs@Tet were assessed. Results: The prepared S-LPs@Tet had an average particle size of 65.57 ± 1.60 nm, a surface charge of − 0.61 ± 0.10 mV, and an encapsulation efficiency of 87.20% ± 1.30%. The S-LPs@Tet released Tet in a sustained manner, and the results demonstrated that the formulation remained stable for one month. More importantly, S-LPs significantly enhanced the inhibitory ability of Tet on the proliferation and migration of lung cancer cells, and enabled Tet to escape phagocytosis by immune cells. Furthermore, in vivo studies confirmed the potential for long-circulation and potent tumor-suppressive effects of S-LPs@Tet. Moreover, ex vivo and in vivo safety experiments demonstrated that the carrier material S-LPs exhibited superior biocompatibility. Conclusion: Our research suggested that S-LPs@Tet has potential applications in lung cancer treatment. Keywords: tetrandrine, S-LPs, lung cancer, immune escape, in vivo imaging Tetrandrine (Tet) is a natural product belonging to the bis-benzylisoquinoline alkaloid family (Figure 1) that was originally isolated and purified from the roots of the traditional Chinese medicinal herb Stephania tetrandra S. Moore . 1 Multiple studies have shown that Tet has a wide range of diverse pharmacological effects. The antitumor effect of Tet is a widely investigated pharmacological activity, primarily achieved through direct inhibition of cell proliferation, induction of apoptosis and autophagy in cancer cells, inhibition of migration and invasion of tumor cells, and reversal of multidrug resistance in tumor cells, among other mechanisms. 2–4 Figure 1 ( A ) The Stephania tetrandra S. Moore and ( B ) molecular structure of Tet. Tet tablets and injections are currently available on the market. However, due to the poor aqueous solubility of Tet, its tablets are not easily absorbed by the human body and have low bioavailability. 5 Additionally, Tet Injection has the side effect of localized irritation and pain during clinical use. 6,7 Free Tet has a short half-life of 7 hours in plasma 8 and is easily cleared, resulting in poor efficacy. 9,10 Therefore, there is an urgent need to develop a suitable drug delivery system to enhance the bioavailability and therapeutic efficacy of Tet. In recent years, nanotechnology has shown promising applications in tumor treatment. Among these, liposomes (LPs) are the most widely used and stable biological nanoparticles in antitumor research due to their biocompatibility and high utility. Several LPs have been clinically approved as nanodrugs, such as Doxil ® , Dauno Xome ® , and Depocyt ® . LPs have garnered significant attention as traditional drug delivery vehicles due to their relatively simple composition, capacity to effectively encapsulate a wide range of hydrophilic and hydrophobic drugs, and high clinical translational value. 7 However, the main drawback of conventional LPs is that they are easily recognized by the reticuloendothelial system, leading to a short half-life and poor stability. Poly (ethylene glycol)–distearoylphosphatidylethanolamine (DSPE-PEG) is an amphiphilic polymer with a hydrophobic core (DSPE) and a hydrophilic shell (PEG). 11 Therefore, incorporating DSPE-PEG into conventional LPs can not only enhance the solubility of drugs in water, 12 but also facilitate the escape of L -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology